oMeds
All comparisons
Comparison · hormone optimization

Estradiol vs Conjugated Estrogens

Estradiol is the bioidentical estrogen used in modern BHRT, available transdermally and orally. Conjugated equine estrogens (CEE) are a mixture of equine-derived estrogens historically used in synthetic HRT. Contemporary provider-reviewed care favors bioidentical transdermal estradiol where clinically appropriate.

Reviewed by Dr. Laura PurdyMay 29, 2026
Attribute
Estradiol (bioidentical)
Conjugated equine estrogens
Molecule
17β-estradiol (identical to human)
Mixed equine estrogens
Delivery
Transdermal patch, gel, oral, injectable
Oral (most common)
VTE risk
Lower with transdermal delivery
Higher with oral delivery
Biomarker tracking
Serum estradiol read directly
Estradiol read indirectly within mixed pool
Modern positioning
Standard in bioidentical hormone optimization
Legacy; reserved for select indications
Pathway
BHRT
Not offered by oMeds
Choose Estradiol (bioidentical)

Bioidentical estradiol — transdermal where clinically appropriate — is the modern standard in BHRT.

Explore pathway
Choose Conjugated equine estrogens

Conjugated estrogens are legacy therapy and not part of the oMeds BHRT pathway.

Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.

Frequently asked

Are bioidentical hormones safer?

Transdermal estradiol has a favorable cardiovascular and thrombotic profile compared with oral CEE, but every candidacy is provider-reviewed.

Why is transdermal preferred?

It bypasses first-pass hepatic metabolism, reducing VTE risk and lipid disturbance.

Next step

Take the optimization assessment.

The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.

Begin assessment